Previous studies have shown a relationship between coronary or carotid atherosclerosis and C-reactive protein (CRP) concentrations. In the present investigation, we evaluated the relationship between high-sensitivity CRP (hsCRP) concentrations and the presence of atherosclerotic lesions in the renal arteries and/or abdominal aorta. In 95 hypertensive patients who underwent intraarterial DSA on suspicion of renovascular disease, blood was sampled during the procedure for measurement of hsCRP. The presence of atherosclerotic lesions was assessed at the level of the renal arteries and the abdominal aorta. Haemodynamically significant renal artery stenosis was diagnosed when 50% or more stenosis was observed. Patients with fibromuscular disease (n ¼ 8) or incomplete data (n ¼ 4) were excluded from analysis. The results revealed that the median hsCRP concentrations were significantly higher among the 57 patients with atherosclerosis of the aorta and/or renal arteries compared to those in the 26 patients without any angiographic lesions (4.6 vs 1.7 mg/l; Po0.005). Moreover, in patients with renal artery stenosis, levels of hsCRP were higher when the degree of stenosis exceeded 50%. However, the association between hsCRP and the presence of atherosclerosis appeared to be confounded by serum creatinine, creatinine clearance, age and gender. In the whole group a significant inverse relationship was found between creatinine clearance and hsCRP (Po0.05).
Introduction
Over the past decade several new, inflammatory, risk factors for atherosclerosis have emerged like fibrinogen, serum amyloid A and C-reactive protein (CRP). 1, 2 Consequently, it has become generally accepted that atherosclerosis is not only a disorder of lipid accumulation but is also characterized by chronic low-grade inflammation. 1 In this respect, high-sensitivity C-reactive protein (hsCRP) concentrations have been shown to be of particular interest. In several large prospective epidemiological studies, circulating levels of this major acute phase protein have been identified as a strong independent predictor of cardiovascular events in subjects with and without prevalent cardiovascular disease. [3] [4] [5] [6] [7] Furthermore, hsCRP concentrations predict the outcome of myocardial infarction or unstable angina pectoris. [7] [8] [9] [10] Angiographic studies of the human vasculature, visualizing the coronary and carotid arteries, indicate that serum hsCRP levels are related to the extent and severity of atherosclerotic vascular disease. 11, 12 Pathological [13] [14] [15] and experimental 16 studies offer a theoretical basis for the association between CRP and cardiovascular risk since deposits of CRP in the vascular wall colocalize with the terminal complement complex and foam cells. This finding suggests a causal, probably proinflammatory, involvement of CRP in the pathogenesis of vascular disease rather than that CRP simply represents a nonspecific marker of risk. In addition, hsCRP may also have potential in targeting proven therapies for primary prevention of cardiovascular disease. 17, 18 hsCRP is not only a predictor of overt cardiovascular disease, but it also has been associated with the presence and severity of subclinical systemic atherosclerosis as well as the presence of hypertension. 19, 20 Previous angiographic studies have only visualized a limited part of the vascular tree, that is, carotid and coronary arteries. However, in patients suspected of having renovascular disease, both renal arteries and the abdominal aorta are visualized, thus allowing a relatively large part of the arterial system to be evaluated for atherosclerosis. We hypothesized that CRP concentrations would be even more elevated in patients with the combination of hypertension and renovascular disease, when we consider the latter as part of generalized atherosclerosis. 21, 22 Therefore, the present study was designed to determine whether there is a relationship between hsCRP concentrations and the presence and extent of angiographically demonstrated atherosclerotic lesions in hypertensive patients clinically suspected of having renovascular disease.
Patients and methods

Subjects
During a 1-year period, we investigated 95 consecutive patients who had been referred to the hypertension outpatient clinic of the University Hospital of Maastricht and in whom renovascular disease was suspected. The diagnosis of hypertension was made when office systolic blood pressure (SBP) was 4140 mmHg and/or diastolic blood pressure (DBP) 490 mmHg on at least three different occasions. If on the basis of clinical or ultrasound data, renovascular disease was suspected, patients underwent intra-arterial digital subtraction angiography (DSA). Patients were selected for angiography when they fulfilled one or more of the following criteria: treatment-resistant hypertension (elevated blood pressure despite two or more adequately dosed antihypertensive drugs), 420% increase of serum creatinine concentrations induced by an angiotensin-converting enzyme inhibitor, smoking and DBP of more than 110 mmHg, malignant or accelerated hypertension and extra-renal atherosclerosis in two or more different vascular beds. Other causes of secondary hypertension were excluded biochemically before patients underwent angiography of the renal arteries.
Written informed consent was obtained from all patients and the Medical Ethical Committee of the Maastricht University hospital had approved the study protocol.
Angiography
The angiographic procedure was carried out in the angiosuite of the Department of Radiology. Following selective catheterization of the renal vessels and before any intra-arterial contrast material was given, blood samples were drawn simultaneously from the abdominal aorta and both renal veins for determination of active plasma renin concentration (APRC). Intra-arterial DSA was performed with a commercially available digital subtraction system (Integris 5000; Philips Medical Systems; Best, The Netherlands). Angiographic images of the abdominal aorta and renal arteries were obtained in anteroposterior, and left and right oblique views with injection of 30 ml iohexol (Omnipaque 300; Nycomed, Oslo, Norway) through a 4-F Universal Flush catheter (Cordis Europe, Roden, The Netherlands) positioned at the level of the renal arteries.
Laboratory measurements
At the time of DSA, blood was collected for measurement of hsCRP, plasma cholesterol, glucose and serum creatinine concentrations. A volume of 2 ml of serum was obtained by centrifugation and stored at À801C until analysis. hsCRP analysis was performed using the IMMULITE method (Diagnostic Products Corporation, Los Angeles, CA, USA), which has been standardized according to the World Health Organization's First International Standard CRP. This alkaline phosphatase-labelled immunometric assay uses a two-site chemiluminescent enzyme with one ligand labelled monoclonal and one polyclonal anti-CRP antibody. A 1:100 manual dilution provides a measurable range of 0.1-500 mg/l. 23 The detection limit for hsCRP is 0.10 mg/l, and the precision (coefficient of variation) is 4%. Plasma cholesterol and glucose were determined using standard methods with commercially available kits. Serum creatinine was measured on the Beckman Coulter Synchron LX-20 system (Beckman Coulter, Inc., Fullenton, CA, USA). Creatinine clearance was calculated using the Cockcroft and Gault formula. 24 APRC was measured by a two-site direct immunoassay (Nichols Institute Diagnostics, San Juan Capistrano, CA, USA). 25 
Radiological evaluation
Digital subtraction angiographic images were reviewed by two independent radiologists for the presence or absence of atherosclerotic lesions in both renal arteries and the aorta below the diaphragm. Final results were based on consensus. If the two radiologists did not agree, a third independent radiologist re-evaluated the images and defined the outcome of these cases. The presence of a haemodynamically significant renal artery stenosis was recorded as well. The latter was based on the following criteria: more than 50% stenosis in one or both of the renal arteries and/or an indication for renal artery angioplasty (veno-arterial renin ratio 41.5). Patients in whom fibromuscular dysplasia (FMD) was diagnosed, were excluded from analysis. Readers were blinded for the results of the hsCRP measurements.
Statistical analysis
The characteristics of the patients enrolled are presented as frequencies or mean values and standard deviation. Medians and ranges or logtransformed data are used to describe variables with a non-normal distribution. Differences in means were assessed by a t-test for independent samples, and differences in frequencies were tested using w 2 statistics. The Mann-Whitney or Kruskal-Wallis tests were used for data that were not normally distributed. The association between CRP concentrations and the presence of atherosclerotic lesions in aorta and/or renal arteries was determined by calculating the median value of the hsCRP concentrations for two separate groups: patients without any atherosclerotic lesions and patients with atherosclerotic lesions in aorta and/or renal arteries. For describing the specific relation between hsCRP and atherosclerosis of the renal arteries, patients were divided into three groups: a group without renal atherosclerosis, a group with renal artery stenosis less than 50% and a group with haemodynamically significant stenosis. The relation between hsCRP and serum creatinine concentration (or creatinine clearance) was determined using Spearman's rank correlation. Associations between hsCRP concentrations and several atherogenic risk factors were studied in univariate linear models. Subsequently, those variables showing a significant correlation with hsCRP were included in a model for multivariate regression analysis.
A P-value less than 0.05 was considered statistically significant. Analyses were performed with SSPS software (SSPS Chicago, IL, USA) using a personal computer.
Results
Statistical analyses were based on 83 out of the 95 patients included in the study. In total, 12 patients were excluded from analysis because of incomplete data (n ¼ 4) or a diagnosis of FMD (n ¼ 8). Atherosclerotic lesions were found in 57 patients (mean age 5979 years), of whom 31 (mean age 6179 years) had lesions in both the aorta and at least one renal artery. Only 10 patients (mean age 56712 years) were found to have renal artery stenosis without any signs of aortic vascular disease, while the atherosclerotic lesions were limited to the abdominal aorta in 16 patients. No differences in clinical features were found between subjects with renal artery stenosis only and those with both renal and aortic atherosclerotic vascular abnormalities. A haemodynamically significant renal artery stenosis was documented in 14 subjects.
The clinical characteristics of the subjects analysed are presented in Table 1 . The distribution of risk factors differed significantly between subjects. Compared to those without atherosclerosis, patients with documented atherosclerosis were significantly older, more often male and had higher total cholesterol and serum creatinine concentrations and a lower creatinine clearance. Moreover, the atherosclerotic group comprised more smokers than the group without lesions and tended to have a higher fasting blood glucose. Although SBP was, on average, higher in those with atherosclerosis than in those without, the difference between the groups just failed to reach statistical significance. Remarkably, serum creatinine concentrations were significantly higher in patients with atherosclerosis than in those without, even when abnormalities were confined to the aorta. Data are presented as mean and standard deviation or frequency. a P-value for the differences between subjects without and with atherosclerotic lesions of the aorta and/or renal arteries.
hsCRP concentrations were significantly higher among patients with any form of atherosclerosis than among those without atherosclerosis with medians of 4.6 mg/l (range: 0.4-43.8 mg/l) and 1.7 mg/l (range: 0.3-12.7 mg/l), respectively (P ¼ 0.004; Figure 1 ). In patients who had 'isolated' renal artery atherosclerosis, the median hsCRP level was 3.3 mg/l while the medians were 4.8 mg/l in patients who had aortic atherosclerosis only or combined aortic and renal atherosclerosis (P ¼ 0.02 for trend; Figure 1 ). Median hsCRP concentrations were 3.5 and 5.3 mg/l, respectively, in patients with less than 50% or more than 50% stenosis of the renal artery but this difference was not statistically significant.
In the patients with atherosclerotic abnormalities, univariate regression analyses showed a positive association between log-hsCRP levels and age (R 2 ¼ 0.09; P ¼ 0.025) and between hsCRP and serum creatinine (R 2 ¼ 0.09; P ¼ 0.025). An inverse correlation was found between hsCRP and creatinine clearance, which was best described by an exponential function (P ¼ 0.02; Figure 2 ). Multivariate analysis with age and serum creatinine as predictors yielded a highly significant model (R 2 ¼ 0.40; P ¼ 0.011), in which serum creatinine remained as an independent determinant of hsCRP (R 2 ¼ 0.14; P ¼ 0.002). These results did not change even when the SBP was forced into the model.
Two patients with documented atherosclerosis had relatively high CRP concentrations (43.8 and 42.1 mg/l); however, excluding these patients from the analyses did not influence the results of this study.
Discussion
In the present study, the association between CRP concentrations and atherosclerosis has been assessed in a population of hypertensive patients in whom renal artery stenosis was suspected. We found that a high percentage (69%) of the patients had atherosclerotic lesions in aorta and/or renal arteries and that the median hsCRP concentration of those patients (4.6 mg/l) was significantly higher compared to the median hsCRP concentration (1.7 mg/l) of the patients without any documented atherosclerosis. Moreover, hsCRP levels are lowest when only the renal artery is affected but substantially higher when aortic lesions, either alone or in combination with renal artery stenosis, are present.
The median hsCRP concentration that we found in the subjects without atherosclerosis, is close to that reported for never-treated hypertensive individuals (1.8 mg/l) by Schillaci et al. 19 On the other hand, it is also similar to the average concentration in over 5000 apparently healthy Americans (1.6 mg/l). 17 Taken together, our findings suggest that elevated hsCRP concentrations should be attributed to atherosclerosis and not to hypertension by itself. Consequently, the relationship between CRP and hypertension as previously reported by Bautista et al 20 and by Sesso et al 26 should be reconsidered. Both studies documented a relationship between hsCRP levels and either the presence 20 or future development 26 of hypertension. Although Sesso and co-workers suggested that hypertension is in part an inflammatory disorder, it may well be that their results indicated more about the atherosclerotic burden associated with an elevated pressure rather than hypertension itself. Most of the hsCRP concentrations of our hypertensive patients with documented atherosclerosis would have been found in the highest quintile of healthy Americans 17 and are well above the cutoff value of 3 mg/l, that is used to identify patients with unstable angina pectoris. 8, 27 As a corollary, the hsCRP concentrations that we found in the present study indicate that some of our hypertensive patients have a high risk of developing a future vascular event and their angiographic findings certainly favour this suggestion.
Previous studies 5, 11, 12 have already demonstrated a relationship between CRP levels and angiographically documented atherosclerosis. In these studies, the carotid and coronary arteries were investigated and patients were mainly selected on the basis of symptoms. In the present study, however, a much larger portion of the vascular tree was investigated and patients were not selected because they had symptoms, but because renovascular disease was suspected on clinical grounds. Our present findings strongly support the use of hsCRP concentrations as an adjunct for global risk assessment. Although hsCRP levels tended to be higher in patients with more severe renal artery stenosis, the relationship failed to reach statistical significance. Although this may be due to small numbers, it could also mean that, once aortic lesions are present, renal artery atherosclerotic plaques do not add much to the height of the CRP concentration. This suggests that aortic and not renal atherosclerosis is the main cause of the increase in hsCRP. In univariate regression analyses, serum creatinine (or creatinine clearance) and age appeared to confound the association between CRP and documented atherosclerosis. While age is a well-known risk factor for atherosclerosis, the association between serum creatinine or creatinine clearance and the presence of atherosclerosis needs further clarification. Our study found that patients with atherosclerosis had significantly higher serum creatinine concentrations as compared to those without atherosclerosis. Even the patients with only aortic atherosclerotic lesions and no renal artery atherosclerosis showed significantly higher serum creatinine concentrations. Although the explanation for this finding is not readily apparent, it may be related to the presence of nephrosclerosis.
Determination of serum creatinine is recommended in hypertensive patients to assess the severity of hypertension-related renal damage. Recently, Schillaci et al 28 found that creatinine concentrations, even in the conventionally accepted reference range, behaved as a predictor of cardiovascular morbidity in hypertensive patients without renal artery stenosis. Likewise, De Leeuw et al 29 showed in the Systolic Hypertension in Europe study (Syst-Eur) that higher levels of serum creatinine are associated with an increased number of cardiovascular events and a higher mortality in patients with isolated systolic hypertension. Thus, one may conclude that serum creatinine concentrations reflect the presence of subclinical atherosclerosis. Moreover, Baggio et al 30 found that subclinical abnormalities in renal function may exist in patients with extrarenal atherosclerosis, particularly in those with classical cardiovascular risk factors. The present study confirms these findings by demonstrating that in patients with atherosclerosis, higher serum creatinine concentrations or lower creatinine clearances coincide with higher hsCRP concentrations, perhaps as a marker for the presence of intrarenal microcirculatory abnormalities.
The inverse correlation between hsCRP and creatinine clearance also raises the question as to whether there is an interaction between renal function and the elimination of CRP. Animal studies support such an interaction. In a study by Motie et al, 31 several iodinated forms of CRP were injected in vivo in CD-1 mice for analysis of their pharmacokinetics and biodistribution. It was found that all forms of CRP were excreted through the urinary tract, presumably after filtration through the kidney. No substantial accumulation of the radiolabel in the kidney was observed. In an earlier study, Vigushin et al 32 had already reported that the kidney is the primary organ for excretion of CRP-associated radiolabels in humans. Therefore, both the atherosclerosis-associated inflammation as well as kidney function may influence CRP concentrations.
In conclusion, hsCRP concentrations are significantly associated with the presence of generalized atherosclerosis and/or atherosclerosis of the renal artery. Furthermore, lower creatinine clearances and higher serum creatinine concentrations were found in patients with documented atherosclerosis. The kidney may play an additional role by modifying the elimination of CRP, especially in patients with atherosclerosis.
What is known on this topic K Atherosclerosis is associated with inflammation as evidenced by, for example, an elevation of CRP. K Angiographic studies indicate that hsCRP levels are related to the extent and severity of atherosclerotic vascular disease. K hsCRP also tend to be increased in hypertension although it has not been settled whether the association is related to hypertension per se or to hypertension-related atherosclerosis.
What this study adds K The data from the present study show that an increased concentration of hsCRP in hypertensive patients is indicative of the presence of atherosclerosis; in other words, hypertension per se does not seem to lead to an elevation of hsCRP. K hsCRP levels are also increased when atherosclerosis is confined to the renal arteries. However, levels are even higher when renal artery stenosis is accompanied by atherosclerotic lesions in the abdominal aorta. K In hypertensive patients, hsCRP levels are inversely related to renal function as assessed from calculated creatinine clearance.
